164. Oculocutaneous albinism Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 16 / Drugs : 44 - (DrugBank : 27) / Drug target genes : 30 - Drug target pathways : 137
| Other names | Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; | ||
|---|---|---|---|
| Disease group | Eye diseases | ||
|
Domestic patients
Med expenses recipients (FY2023) |
34 patients Age distribution
 💬 |
||
| Related info (in Japanese) | - | ||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 10-4-31. Chédiak-Higashi syndrome; CHS | ||
| 14-1-1. oculocutaneous albinism; OCA | |||
| Subtypes | - | ||